These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32603203)

  • 1. Mometasone furoate-loaded aspasomal gel for topical treatment of psoriasis: formulation, optimization,
    Shinde G; Desai P; Shelke S; Patel R; Bangale G; Kulkarni D
    J Dermatolog Treat; 2022 Mar; 33(2):885-896. PubMed ID: 32603203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
    Kaur N; Sharma K; Bedi N
    Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Niosomal Vesicles Loaded Mometasone Furoate Gel for Transdermal Delivery and its Evaluation.
    Rane BR; Chavan PY; Kate NS; Jain AS
    Recent Adv Drug Deliv Formul; 2023; 17(4):300-313. PubMed ID: 37974444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbic acid derivative-loaded modified aspasomes: formulation,
    Aboul-Einien MH; Kandil SM; Abdou EM; Diab HM; Zaki MSE
    J Liposome Res; 2020 Mar; 30(1):54-67. PubMed ID: 30821553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery.
    Madan JR; Khude PA; Dua K
    Int J Pharm Investig; 2014 Apr; 4(2):60-4. PubMed ID: 25006550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.
    Guenther LC; Poulin YP; Pariser DM
    Clin Ther; 2000 Oct; 22(10):1225-38. PubMed ID: 11110233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbyl palmitate vesicles (Aspasomes): formation, characterization and applications.
    Gopinath D; Ravi D; Rao BR; Apte SS; Renuka D; Rambhau D
    Int J Pharm; 2004 Mar; 271(1-2):95-113. PubMed ID: 15129977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Karanjin-loaded soya lecithin-based ethosomal nanogel for the therapeutic intervention of psoriasis: formulation development, factorial design based-optimization,
    Mujtaba MA; Gangane P; Ali A; Chaudhari S; Kaleem M; More S; Shahzad N; Elhassan GO; Anwer MK
    Biomed Mater; 2024 Jul; 19(5):. PubMed ID: 38955335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability, antipsoriatic efficacy and tolerability of a new light cream with mometasone furoate 0.1%.
    Korting HC; Schöllmann C; Willers C; Wigger-Alberti W
    Skin Pharmacol Physiol; 2012; 25(3):133-41. PubMed ID: 22353786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical treatment for scalp psoriasis: Comparison of patient preference, quality of life and efficacy for non-alcoholic mometasone emulsion versus calcipotriol/betamethasone gel in daily clinical practice.
    Gual A; Pau-Charles I; Molin S
    J Dermatolog Treat; 2016; 27(3):228-34. PubMed ID: 26503824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids.
    Spada F; Barnes TM; Greive KA
    Australas J Dermatol; 2018 Aug; 59(3):e168-e174. PubMed ID: 29411351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo-in vivo evaluation study.
    Abu Hashim II; Abo El-Magd NF; El-Sheakh AR; Hamed MF; Abd El-Gawad AEH
    Int J Nanomedicine; 2018; 13():1059-1079. PubMed ID: 29503541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsoriatic and Anti-inflammatory Studies of
    Nimisha ; Rizvi DA; Fatima Z; Neema ; Kaur CD
    Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S587-S594. PubMed ID: 29142419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
    Poulin YP
    Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis.
    Altuntaş E; Yener G
    AAPS PharmSciTech; 2017 Oct; 18(7):2673-2682. PubMed ID: 28281209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the Slow-Release Mometasone Furoate Injection of PLGA for the Treatment of Knee Arthritis.
    Liang Y; Zhang J; Zhao X; Wang M; Ding S; Wang Y; Chen Y; Liu J
    Curr Drug Deliv; 2021; 18(3):357-368. PubMed ID: 32940181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterisation of clobetasol propionate loaded Squarticles as a lipid nanocarrier for treatment of plaque psoriasis.
    Dadwal A; Mishra N; Rawal RK; Narang RK
    J Microencapsul; 2020 Aug; 37(5):341-354. PubMed ID: 32293928
    [No Abstract]   [Full Text] [Related]  

  • 18. Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis.
    Iriventi P; Gupta NV; Osmani RAM; Balamuralidhara V
    Daru; 2020 Dec; 28(2):489-506. PubMed ID: 32472531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris.
    Tiplica GS; Salavastru CM
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):905-12. PubMed ID: 19470062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study.
    Koo J; Cuffie CA; Tanner DJ; Bressinck R; Cornell RC; DeVillez RL; Edwards L; Breneman DL; Piacquadio DJ; Guzzo CA; Monroe EW
    Clin Ther; 1998; 20(2):283-91. PubMed ID: 9589819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.